Total Payments
$631,123
2024 Payments
$96,745
Companies
6
Transactions
661
Medicare Patients
188
Medicare Billing
$15,506
Payment Breakdown by Category
Other$463,884 (73.5%)
Consulting$100,035 (15.9%)
Travel$56,673 (9.0%)
Food & Beverage$10,531 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $455,863 | 216 | 72.2% |
| Consulting Fee | $100,035 | 31 | 15.9% |
| Travel and Lodging | $56,673 | 252 | 9.0% |
| Food and Beverage | $10,531 | 159 | 1.7% |
| Honoraria | $5,180 | 2 | 0.8% |
| Grant | $2,841 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $249,344 | 238 | $0 (2024) |
| Merck Sharp & Dohme LLC | $126,598 | 144 | $0 (2024) |
| PFIZER INC. | $126,311 | 164 | $0 (2024) |
| SANOFI PASTEUR INC. | $125,957 | 113 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $2,841 | 1 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $71.07 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $96,745 | 84 | GlaxoSmithKline, LLC. ($67,185) |
| 2023 | $113,601 | 91 | GlaxoSmithKline, LLC. ($88,078) |
| 2022 | $91,253 | 81 | GlaxoSmithKline, LLC. ($67,872) |
| 2021 | $47,041 | 46 | GlaxoSmithKline, LLC. ($21,883) |
| 2020 | $68,676 | 60 | SANOFI PASTEUR INC. ($33,956) |
| 2019 | $79,435 | 91 | Merck Sharp & Dohme Corporation ($45,231) |
| 2018 | $90,464 | 134 | PFIZER INC. ($41,203) |
| 2017 | $43,909 | 74 | PFIZER INC. ($31,048) |
All Payment Transactions
661 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $44.01 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | Cash or cash equivalent | $27.31 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $27.17 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | Cash or cash equivalent | $52.54 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $26.17 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,730.00 | General |
| Category: VACCINE | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: VACCINE | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $1,212.48 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $300.71 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 11/28/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: VACCINE | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $982.64 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $204.06 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $122.02 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $1,675.39 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $173.39 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: VACCINE | ||||||
| 11/08/2024 | PFIZER INC. | COMIRNATY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,250.00 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | PFIZER INC. | COMIRNATY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,250.00 | General |
| Category: VACCINES | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 18 | $3,580 | $907.56 |
| 2022 | 2 | 23 | 23 | $9,237 | $2,441 |
| 2021 | 2 | 49 | 50 | $19,762 | $5,531 |
| 2020 | 3 | 100 | 102 | $27,048 | $6,626 |
Total Patients
188
Total Services
193
Medicare Billing
$15,506
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 18 | $3,580 | $907.56 | 25.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $6,048 | $1,572 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 12 | $3,189 | $869.60 | 27.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 25 | 25 | $13,422 | $3,571 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 24 | 25 | $6,340 | $1,960 | 30.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 26 | 26 | $13,220 | $3,456 | 26.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 62 | 64 | $10,936 | $2,423 | 22.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 12 | 12 | $2,892 | $746.85 | 25.8% |
About Dr. Martin Mahoney, MD
Dr. Martin Mahoney, MD is a Family Medicine healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235120296.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Mahoney, MD has received a total of $631,123 in payments from pharmaceutical and medical device companies, with $96,745 received in 2024. These payments were reported across 661 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($455,863).
As a Medicare-enrolled provider, Mahoney has provided services to 188 Medicare beneficiaries, totaling 193 services with total Medicare billing of $15,506. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Buffalo, NY
- Active Since 10/31/2005
- Last Updated 01/20/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235120296
Products in Payments
- SHINGRIX (Biological) $165,611
- AREXVY (Drug) $79,092
- CHANTIX (Drug) $69,246
- FLUZONE HIGH-DOSE (Drug) $52,759
- GARDASIL (Biological) $50,314
- FLUZONE HIGH-DOSE (Biological) $27,897
- PNEUMOVAX 23 (Biological) $18,330
- ABRYSVO (Biological) $15,814
- GARDASIL 9 (Biological) $15,377
- VAXNEUVANCE (Biological) $14,599
- FLUZONE QUADRIVALENT (Drug) $10,881
- COMIRNATY (Biological) $10,300
- PREVNAR 20 (Biological) $10,080
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $8,493
- PREVNAR 13 (Biological) $5,180
- PREVNAR - 13 (Biological) $5,081
- CAPVAXIVE (Biological) $4,830
- MENQUADFI (Biological) $4,621
- ZOSTAVAX (Biological) $3,230
- FLUBLOK QUADRIVALENT (Drug) $2,858
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Buffalo
Michael Zionts, Md, MD
Family Medicine — Payments: $21,271
Family Medicine $21,271
Dr. Kelly Kinnan, M.d, M.D
Family Medicine — Payments: $18,189
Family Medicine $18,189
Dr. Raul Vazquez, M.d, M.D
Family Medicine — Payments: $14,950
Family Medicine $14,950
Dr. Ryan Bowe, Md, MD
Family Medicine — Payments: $11,387
Family Medicine $11,387
Chester Fox, Md, MD
Family Medicine — Payments: $11,324
Family Medicine $11,324
Maritza Baez, Md, MD
Family Medicine — Payments: $5,578
Family Medicine $5,578